Mariana Franzoni Maioral
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mariana Franzoni Maioral has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Maria Cláudia Santos-Silva
Experimental Oncology and Hemopathies Laboratory, Clinical Analysis Department, Federal University of Santa Catarina, Florianópolis, Brazil
4 shared publications Álisson Bigolin
Post-Graduation Program in Pharmacy, Health Science Center, Federal University of Santa Catarina, Florianópolis, Brazil
2 shared publicationsAlessandra Mascarello
Structure and Activity Laboratory, Chemistry Department, Federal University of Santa Catarina, Florianópolis, Brazil
1 shared publicationAna Cláudia Philippus
Post-Graduation Program in Pharmacy, Health Science Center, Federal University of Santa Catarina, Florianópolis, SC, CEP: 88040-900, Brazil
1 shared publicationDouglas B. Speer
Experimental Oncology and Hemopathies Laboratory, Clinical Analysis Department Federal University of Santa Catarina Florianópolis Santa Catarina Brazil
1 shared publicationGabriele Andressa Zatelli
Post-Graduation Program in Pharmacy, Health Science Center, Federal University of Santa Catarina, Florianópolis, SC, CEP: 88040-900, Brazil
1 shared publication
Latest Publications
- 7 February 2022
- Published by Wiley in Environmental Toxicology
- Vol. 37 (6) , 1297-1309
Involvement of the NF‐κB and PI3K/Akt/mTOR pathways in cell death triggered by stypoldione, an o‐quinone isolated from the brown algae Stypopodium zonale
Multiple myeloma (MM) is a clonal plasma cell malignancy that remains incurable to date. Thus, the aims of this study were to evaluate the involvement of the NF‐κB and PI3K/Akt/mTOR pathways in the cytotoxicity of stypoldione, an o‐quinone isolated from the brown algae Stypopodium zonale, in MM cells (MM1.S). The cytotoxic effect was evaluated in MM1.S cells and peripheral blood mononuclear cells (PBMCs) by MTT assay. The stypoldione reduced the cell viability of MM1.S cells in a concentration and time‐dependent manner (IC50 in MM.1S from 2.55 to 5.38 μM). However, it was also cytotoxic to PBMCs, but at a lower range. Additionally, no significant hemolysis was observed even at concentration up to 10 times the IC50. Apoptotic cell death was confirmed by cell morphology and Annexin V‐FITC assay. Stypoldione induced intrinsic and extrinsic apoptosis by increasing FasR expression and reactive oxygen species (ROS) production, inverting the Bax/Bcl‐2 ratio, and inducing ΔΨm loss, which resulted in AIF release and caspase‐3 activation. It also increased Ki‐67 and survivin expression and inhibited the NF‐κB and PI3K/Akt/mTOR pathways. These results suggest that stypoldione is a good candidate for the development of new drugs for MM treatment.
- 7 February 2022
- Published by Wiley in Environmental Toxicology
- Vol. 37 (6) , 1297-1309
Involvement of the NF‐κB and PI3K/Akt/mTOR pathways in cell death triggered by stypoldione, an o‐quinone isolated from the brown algae Stypopodium zonale
Multiple myeloma (MM) is a clonal plasma cell malignancy that remains incurable to date. Thus, the aims of this study were to evaluate the involvement of the NF‐κB and PI3K/Akt/mTOR pathways in the cytotoxicity of stypoldione, an o‐quinone isolated from the brown algae Stypopodium zonale, in MM cells (MM1.S). The cytotoxic effect was evaluated in MM1.S cells and peripheral blood mononuclear cells (PBMCs) by MTT assay. The stypoldione reduced the cell viability of MM1.S cells in a concentration and time‐dependent manner (IC50 in MM.1S from 2.55 to 5.38 μM). However, it was also cytotoxic to PBMCs, but at a lower range. Additionally, no significant hemolysis was observed even at concentration up to 10 times the IC50. Apoptotic cell death was confirmed by cell morphology and Annexin V‐FITC assay. Stypoldione induced intrinsic and extrinsic apoptosis by increasing FasR expression and reactive oxygen species (ROS) production, inverting the Bax/Bcl‐2 ratio, and inducing ΔΨm loss, which resulted in AIF release and caspase‐3 activation. It also increased Ki‐67 and survivin expression and inhibited the NF‐κB and PI3K/Akt/mTOR pathways. These results suggest that stypoldione is a good candidate for the development of new drugs for MM treatment.
- 19 March 2020
- Published by Springer Nature in Chemical Papers
- Vol. 74 (9) , 2965-2976
A novel sulfonamide derivative as a strong and selective apototic agent against hematological malignancies
- 19 March 2020
- Published by Springer Nature in Chemical Papers
- Vol. 74 (9) , 2965-2976
A novel sulfonamide derivative as a strong and selective apototic agent against hematological malignancies
- 19 March 2020
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 12 (8) , 673-688
Aldehyde Biphenyl Chalcones Induce Immunogenic apoptotic-like Cell Death and are Promising New Safe Compounds Against a Wide Range of Hematologic Cancers
Aim: Investigate the apoptotic mechanisms of two new aldehyde biphenyl chalcones on leukemia cells. Materials & methods: From a series of 71 new chalcones, we selected the two most cytotoxic. Resul... Graphical abstract
- 19 March 2020
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 12 (8) , 673-688
Aldehyde Biphenyl Chalcones Induce Immunogenic apoptotic-like Cell Death and are Promising New Safe Compounds Against a Wide Range of Hematologic Cancers
Aim: Investigate the apoptotic mechanisms of two new aldehyde biphenyl chalcones on leukemia cells. Materials & methods: From a series of 71 new chalcones, we selected the two most cytotoxic. Resul... Graphical abstract
- 19 December 2018
- Published by Springer Nature in Investigational New Drugs
- Vol. 37 (5) , 912-922
MICONIDINE acetate, a new selective and cytotoxic compound with synergic potential, induces cell cycle arrest and apoptosis in leukemia cells
Plants are important sources of biologically active compounds and they provide unlimited opportunities for the discovery and development of new drug leads, including new chemotherapeutics. Miconidin acetate (MA) is a hydroquinone derivative isolated from E. hiemalis. In this study we demonstrated that MA was cytotoxic against acute leukemia (AL), solid tumor cells and cancer stem cells, with the strongest effect exhibited against AL. Furthermore, it was non-cytotoxic against non-tumor cells and did not cause significant hemolysis. MA blocks the G2/M phase and causes cytostatic effects, acting in a similar way to dexamethasone by increasing PML expression. The compound also triggered intrinsic and extrinsic apoptosis by modulating Bax, FasR and survivin expression. This led to an extensive mitochondrial damage that resulted in AIF, cytochrome c and endonuclease G release, caspase-3 and PARP cleavage and DNA fragmentation. We have further demonstrated that MA was strongly cytotoxic against neoplastic cells collected from patients with different AL subtypes. Interestingly, MA increased the cytotoxic effect of chemotherapeutics cytarabine and vincristine. This study indicates that MA may be a new agent for AL and highlights its potential as a new source of anticancer drugs.
- 19 December 2018
- Published by Springer Nature in Investigational New Drugs
- Vol. 37 (5) , 912-922
MICONIDINE acetate, a new selective and cytotoxic compound with synergic potential, induces cell cycle arrest and apoptosis in leukemia cells
Plants are important sources of biologically active compounds and they provide unlimited opportunities for the discovery and development of new drug leads, including new chemotherapeutics. Miconidin acetate (MA) is a hydroquinone derivative isolated from E. hiemalis. In this study we demonstrated that MA was cytotoxic against acute leukemia (AL), solid tumor cells and cancer stem cells, with the strongest effect exhibited against AL. Furthermore, it was non-cytotoxic against non-tumor cells and did not cause significant hemolysis. MA blocks the G2/M phase and causes cytostatic effects, acting in a similar way to dexamethasone by increasing PML expression. The compound also triggered intrinsic and extrinsic apoptosis by modulating Bax, FasR and survivin expression. This led to an extensive mitochondrial damage that resulted in AIF, cytochrome c and endonuclease G release, caspase-3 and PARP cleavage and DNA fragmentation. We have further demonstrated that MA was strongly cytotoxic against neoplastic cells collected from patients with different AL subtypes. Interestingly, MA increased the cytotoxic effect of chemotherapeutics cytarabine and vincristine. This study indicates that MA may be a new agent for AL and highlights its potential as a new source of anticancer drugs.